Effect of Maternal BMI on Measurement of Cervical Length
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01882738|
Recruitment Status : Unknown
Verified June 2013 by Hillel Yaffe Medical Center.
Recruitment status was: Not yet recruiting
First Posted : June 20, 2013
Last Update Posted : June 20, 2013
|Condition or disease|
This study will include pregnant women in either 2nd or 3rd trimester of pregnancy. All consecutive pregnant patients in 2nd or 3rd trimester who will attend our unit for routine ultrasound exam will be asked to participate. Cervical length will be assessed in all patients, once abdominally and then vaginally (that would serve as golden standard). Correlation would be assessed between accuracy of measurement to BMI. Accuracy would be defind as the delta of cervical length between abdominal and vaginal routs.
BMI would be calculated prior to the ultrasound exam (by weighing and measuring all patients).
|Study Type :||Observational|
|Estimated Enrollment :||300 participants|
|Official Title:||Effect of Maternal BMI on Accuracy of Measurement of Cervical Length During the 3rd Trimester of Pregnancy|
|Study Start Date :||July 2013|
|Estimated Primary Completion Date :||July 2014|
|Estimated Study Completion Date :||July 2015|
- Accuracy of cervical length according to BMI [ Time Frame: 1 year ]the golden standard for cervical length measurement is vaginal scan. Our outcome measure will be the accuracy of cervical length measurement - measured abdominally, according to BMI. I other words - was there a difference between measurement by vaginal probe and abdominal probe and whether this difference correlates with BMI
- Gestational age at delivery according to cervical length [ Time Frame: 1 year ]Gestational age at delivery according to cervical length
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01882738
|Contact: Alon Shrim, MDemail@example.com|
|Contact: Ron Belosseski, MD||+972-50-9205759||Tomor2304@yahoo.com|